1Mizoue T,Kawamoto H,Arita K,et a1.Secretion of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by meningiomas detected by cell immunoblot analysis[J].Acta Neurochir,1999,141(5):481-486.
2Seandel M,Noack-Kunnmann K,Zhu D,et al.Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type Ⅰ collagen[J].Blood,2001,97(8):2323-2332.
4Wang M,Wang M,Liu S,et al.The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades[J].Brain Tumor Pathol,2003,20(2):65-72.
5Berens ME,Rief MD,Loo MA,et al.The role of extracellular matrix in human astrocytoma migration and proliferation studied in a microliter scale assay,Clin,Exp.Metastasis,1994,12(6):405-415.
6Klepper Lia.Method of calculating the equivalent tumor dose as a function as to irradiated tumor tissue volume[J].Med Tekh,2001,4:15-20.
7Korshunov A,Golanov A,Sycheva R.Immunohistochemical markers for prognosis of cerebral glioblastomas[J].Neurooncol,2002,58(3):217-236.
8Kayaselcuk F,Zorludemir S,Gumurduhu D,et al.PCNA and Ki-67 in central nervous system tumors:correlation with the histological type and grade[J].J Neurooncol,2002,57(2):115-121.
3Galand P,Degvaef C.Cyclin PCNA immuno-staining as an alternative to tritiated thymdine pulse labelling for making 5 phase cells in paraffin section from animal and human tissues[].Cell and Tissue Kinetics.1989
4Ogata K,Kurki P,Celis JE et al.Monoclonal antibodies to a nuclear protein (PCNA Cyclin) associated with DNA replication[].Experimental Cell Research.1987
5Bravo R,Frank R,Blundell PA et al.Cyclin PCNA is the auxiliary protein of DNA polymerase-delta[].Nature.1987
6Van Dierendonck,Wisman JH,Keijxer R et al.Cell cyclerelated staining patterns of anti -proliferating cell nuclear antigen monoclonal antibodies , comrarison with Brdurd labelling and Ki -67 staining[].American Journal of Pathology.1991
7Barbareschi M,Iuzzoline P,Pennella Aet al.p53 protein expression in central nervous system neoplasm[].Journal of Clinical Pathology.1992
7[1]Gilhuis HJ,van der Laak JA,Pomp J,et al.Three-dimensional (3D) reconstruction and quantitative analysis of the microvasculature in medulloblastoma and ependymoma subtypes[J].Angiogenesis,2006,9:201.
8[2]Haberler C,Slavc I,Czech T,et al.Histopathological prognostic factors in medulloblastoma:high expression of survivin is related to unfavourable outcome[J].Eur J Cancer,2006,42:2996.
9[3]Ozen O,Krebs B,Hemmerlein B,et al.Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance[J].Clin Cancer Res.2004,10:4746.
10[4]Gajjar A,Hernan R,Kocak M,et al.Clinical,histopathologic,and molecular markers of prognosis:toward a new disease risk stratification system for medulloblastoma[J].J Clin Oncol,2004,22:971.
